Form 4 for ANNX Annexon, Inc.
Accepted 2025-01-08 00:00:00 ET · period of report 2025-01-06 · accession 0001415889-25-001149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-08 | 2025-01-06 | ANNX | Love Douglas | Pres AND CEO, Dir | M - OptEx | $1.41 | +38.0K | 356.6K | +12% | +$53.6K |
| D | 2025-01-08 | 2025-01-06 | ANNX | Love Douglas | Pres AND CEO, Dir | M - OptEx | $0.00 | -38.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-06 | M | A | 37,994 | $1.41 | 356,575 | D | — | — | (F1) Includes 5,514 shares acquired on May 15, 2024 and 2,497 shares acquired on November 15, 2024, pursuant to the Issuer's Employee Stock Purchase Plan. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-01-06 | M | D | 37,994 | $0.00 | 0 | D | $1.41 · — to 2025-01-22 | 37,994 Common Stock | (F2) The shares subject to the option are fully vested and exercisable. |